Try the Demo today!
| SEC Filing | Insider | Company | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Return |
|---|---|---|---|---|---|---|---|---|---|
| 15-Feb-24 4:05 PM View:  | Jimenez Freddy A. SVP & General Counsel | AVANT Immunotherapeutics, I... (CLDX) | 13-Feb-24 | Option Exercise | 24,166 | $3.86 | $93,162.70 | 1375% 1.76K to 25.92K | |
| 04-Jan-24 4:05 PM View: | Martin Samuel Bates SVP and CFO | AVANT Immunotherapeutics, I... (CLDX) | 02-Jan-24 | Option Exercise | 10,750 | $2.78 | $29,885.00 | 44% 24.38K to 35.13K | |
| 09-Dec-22 4:07 PM View: | Keler Tibor Executive VP & CSO | AVANT Immunotherapeutics, I... (CLDX) | 07-Dec-22 | Option Exercise | 16,860 | $2.78 | $46,870.80 | 229% 7.36K to 24.22K | |
| 09-Dec-22 4:07 PM View: | Keler Tibor Executive VP & CSO | AVANT Immunotherapeutics, I... (CLDX) | 07-Dec-22 | Option Sale | 16,860 | $36.93 | $622,611.00 | (70%) 24.22K to 7.36K | |
| 19-Aug-22 4:06 PM View: | Cavanaugh Sarah SVP of Corp Affairs & Admin. | AVANT Immunotherapeutics, I... (CLDX) | 18-Aug-22 | Option Exercise | 1,355 | $9.02 | $12,217.40 | 106% 1.28K to 2.64K | |
| 19-Aug-22 4:06 PM View: | Cavanaugh Sarah SVP of Corp Affairs & Admin. | AVANT Immunotherapeutics, I... (CLDX) | 18-Aug-22 | Option Sale | 1,355 | $36.38 | $49,289.10 | (51%) 2.64K to 1.28K | |
| 19-Aug-22 4:05 PM View: | Young Diane C. SVP, Chief Medical Officer | AVANT Immunotherapeutics, I... (CLDX) | 17-Aug-22 | Option Exercise | 64,000 | $4.99 | $319,170.00 | 3026% 2.12K to 66.11K | |
| 19-Aug-22 4:06 PM View: | Cavanaugh Sarah SVP of Corp Affairs & Admin. | AVANT Immunotherapeutics, I... (CLDX) | 17-Aug-22 | Option Sale | 31,312 | $36.73 | $1,150,220.00 | (96%) 32.6K to 1.28K | |
| 19-Aug-22 4:05 PM View: | Young Diane C. SVP, Chief Medical Officer | AVANT Immunotherapeutics, I... (CLDX) | 17-Aug-22 | Option Sale | 19,000 | $37.30 | $708,715.00 | (29%) 66.11K to 47.12K | |
| 19-Aug-22 4:06 PM View: | Cavanaugh Sarah SVP of Corp Affairs & Admin. | AVANT Immunotherapeutics, I... (CLDX) | 17-Aug-22 | Option Exercise | 31,312 | $2.78 | $87,047.40 | 2439% 1.28K to 32.6K | |
| 17-Aug-22 4:05 PM View: | Wright Richard M. Sr. VP & CCO | AVANT Immunotherapeutics, I... (CLDX) | 15-Aug-22 | Option Sale | 15,328 | $37.71 | $578,048.00 | (99%) 15.54K to 0.21K | |
| 17-Aug-22 4:06 PM View: | Marucci Anthony S President & CEO Director | AVANT Immunotherapeutics, I... (CLDX) | 15-Aug-22 | Option Exercise | 120,000 | $5.12 | $614,242.00 | 433% 27.69K to 147.69K | |
| 17-Aug-22 4:05 PM View: | Wright Richard M. Sr. VP & CCO | AVANT Immunotherapeutics, I... (CLDX) | 15-Aug-22 | Option Exercise | 15,328 | $10.38 | $159,105.00 | 7369% 0.21K to 15.54K | |
| 17-Aug-22 4:06 PM View: | Marucci Anthony S President & CEO Director | AVANT Immunotherapeutics, I... (CLDX) | 15-Aug-22 | Option Sale | 120,000 | $37.66 | $4,519,570.00 | (81%) 147.69K to 27.69K | |
| 15-Aug-22 4:16 PM View: | Martin Samuel Bates SVP and CFO | AVANT Immunotherapeutics, I... (CLDX) | 12-Aug-22 | Option Exercise | 17,547 | $4.16 | $72,953.30 | 72% 24.38K to 41.92K | |
| 15-Aug-22 4:16 PM View: | Martin Samuel Bates SVP and CFO | AVANT Immunotherapeutics, I... (CLDX) | 12-Aug-22 | Option Sale | 17,547 | $36.45 | $639,629.00 | (42%) 41.92K to 24.38K | |
| 15-Aug-22 4:16 PM View: | Martin Samuel Bates SVP and CFO | AVANT Immunotherapeutics, I... (CLDX) | 11-Aug-22 | Option Sale | 2,453 | $37.04 | $90,856.40 | (9%) 26.83K to 24.38K | |
| 15-Aug-22 4:16 PM View: | Martin Samuel Bates SVP and CFO | AVANT Immunotherapeutics, I... (CLDX) | 11-Aug-22 | Option Exercise | 2,453 | $9.02 | $22,117.50 | 10% 24.38K to 26.83K | |
| 28-Dec-21 4:02 PM View: | Martin Samuel Bates SVP and CFO | AVANT Immunotherapeutics, I... (CLDX) | 23-Dec-21 | Market Option Sale (Planned) | 7,000 | $42.00 | $294,000.00 | (21%) 33.88K to 26.88K | |
| 28-Dec-21 4:02 PM View: | Martin Samuel Bates SVP and CFO | AVANT Immunotherapeutics, I... (CLDX) | 23-Dec-21 | Option Exercise | 7,000 | $5.68 | $39,728.60 | 26% 26.88K to 33.88K | |
| 28-Dec-21 4:02 PM View: | Martin Samuel Bates SVP and CFO | AVANT Immunotherapeutics, I... (CLDX) | 23-Dec-21 | Market Sale (Planned) | 2,500 | $42.00 | $105,000.00 | (9%) 26.88K to 24.38K | |
| 10-Dec-21 4:03 PM View: | Cavanaugh Sarah SVP of Corp Affairs & Admin. | AVANT Immunotherapeutics, I... (CLDX) | 08-Dec-21 | Option Exercise | 7,323 | $10.03 | $73,480.70 | 1795% 0.41K to 7.73K | |
| 10-Dec-21 4:02 PM View: | Crowley Elizabeth Sr. VP &CPDO | AVANT Immunotherapeutics, I... (CLDX) | 08-Dec-21 | Market Option Sale (Planned) | 4,000 | $40.00 | $160,000.00 | (46%) 8.73K to 4.73K | |
| 10-Dec-21 4:03 PM View: | Cavanaugh Sarah SVP of Corp Affairs & Admin. | AVANT Immunotherapeutics, I... (CLDX) | 08-Dec-21 | Market Option Sale (Planned) | 7,323 | $40.00 | $292,920.00 | (95%) 7.73K to 0.41K | |
| 10-Dec-21 4:02 PM View: | Crowley Elizabeth Sr. VP &CPDO | AVANT Immunotherapeutics, I... (CLDX) | 08-Dec-21 | Option Exercise | 4,000 | $9.02 | $36,066.00 | 85% 4.73K to 8.73K | |
| 10-Dec-21 4:02 PM View: | Heath-Chiozzi Margo SVP of Regulatory Affairs | AVANT Immunotherapeutics, I... (CLDX) | 08-Dec-21 | Option Exercise | 600 | $2.78 | $1,668.00 | 5% 11.25K to 11.85K | |
| 10-Dec-21 4:02 PM View: | Heath-Chiozzi Margo SVP of Regulatory Affairs | AVANT Immunotherapeutics, I... (CLDX) | 08-Dec-21 | Market Option Sale (Planned) | 600 | $40.00 | $24,000.00 | (5%) 11.85K to 11.25K | |
| 17-Nov-21 4:02 PM View: | Martin Samuel Bates SVP and CFO | AVANT Immunotherapeutics, I... (CLDX) | 15-Nov-21 | Option Exercise | 7,000 | $5.68 | $39,728.60 | 24% 29.38K to 36.38K | |
| 17-Nov-21 4:02 PM View: | Martin Samuel Bates SVP and CFO | AVANT Immunotherapeutics, I... (CLDX) | 15-Nov-21 | Market Option Sale (Planned) | 7,000 | $43.57 | $304,967.00 | (19%) 36.38K to 29.38K | |
| 17-Nov-21 4:02 PM View: | Martin Samuel Bates SVP and CFO | AVANT Immunotherapeutics, I... (CLDX) | 15-Nov-21 | Market Sale (Planned) | 2,500 | $43.57 | $108,917.00 | (9%) 29.38K to 26.88K | |
| 16-Nov-21 4:02 PM View: | Young Diane C. SVP, Chief Medical Officer | AVANT Immunotherapeutics, I... (CLDX) | 12-Nov-21 | Option Exercise | 4,600 | $10.38 | $47,748.00 | 217% 2.12K to 6.71K | |
| 16-Nov-21 4:02 PM View: | Young Diane C. SVP, Chief Medical Officer | AVANT Immunotherapeutics, I... (CLDX) | 12-Nov-21 | Market Option Sale | 4,600 | $42.94 | $197,529.00 | (69%) 6.71K to 2.12K | |
| 03-Nov-21 4:02 PM View: | Cavanaugh Sarah SVP of Corp Affairs & Admin. | AVANT Immunotherapeutics, I... (CLDX) | 01-Nov-21 | Market Sale (Planned) | 1,367 | $43.26 | $59,138.50 | (77%) 1.77K to 0.41K | |
| 03-Nov-21 4:02 PM View: | Crowley Elizabeth Sr. VP &CPDO | AVANT Immunotherapeutics, I... (CLDX) | 01-Nov-21 | Option Exercise | 8,555 | $2.78 | $23,782.90 | 1753% 0.49K to 9.04K | |
| 03-Nov-21 4:02 PM View: | Heath-Chiozzi Margo SVP of Regulatory Affairs | AVANT Immunotherapeutics, I... (CLDX) | 01-Nov-21 | Option Exercise | 600 | $2.78 | $1,668.00 | 5% 11.25K to 11.85K | |
| 03-Nov-21 4:02 PM View: | Heath-Chiozzi Margo SVP of Regulatory Affairs | AVANT Immunotherapeutics, I... (CLDX) | 01-Nov-21 | Market Option Sale (Planned) | 600 | $41.71 | $25,026.00 | (5%) 11.85K to 11.25K | |
| 03-Nov-21 4:02 PM View: | Cavanaugh Sarah SVP of Corp Affairs & Admin. | AVANT Immunotherapeutics, I... (CLDX) | 01-Nov-21 | Option Exercise | 5,956 | $8.03 | $47,852.40 | 336% 1.77K to 7.73K | |
| 03-Nov-21 4:02 PM View: | Cavanaugh Sarah SVP of Corp Affairs & Admin. | AVANT Immunotherapeutics, I... (CLDX) | 01-Nov-21 | Market Option Sale (Planned) | 5,956 | $43.26 | $257,666.00 | (77%) 7.73K to 1.77K | |
| 03-Nov-21 4:02 PM View: | Crowley Elizabeth Sr. VP &CPDO | AVANT Immunotherapeutics, I... (CLDX) | 01-Nov-21 | Market Option Sale (Planned) | 4,317 | $43.29 | $186,874.00 | (48%) 9.04K to 4.73K | |
| 13-Aug-21 6:59 AM View: | Heath-Chiozzi Margo SVP of Regulatory Affairs | AVANT Immunotherapeutics, I... (CLDX) | 11-Aug-21 | Option Exercise | 10,000 | $9.02 | $90,165.00 | 802% 1.25K to 11.25K | |
| 13-Aug-21 6:58 AM View: | Jimenez Freddy A. SVP & General Counsel | AVANT Immunotherapeutics, I... (CLDX) | 11-Aug-21 | Market Purchase | 430 | $46.28 | $19,900.40 | 100% 0 to 0.43K | (2%) |
| 12-Aug-21 10:00 AM View: | Martin Samuel Bates SVP and CFO | AVANT Immunotherapeutics, I... (CLDX) | 10-Aug-21 | Market Option Sale | 2,738 | $45.25 | $123,894.00 | (9%) 32.12K to 29.38K | |
| 12-Aug-21 10:00 AM View: | Martin Samuel Bates SVP and CFO | AVANT Immunotherapeutics, I... (CLDX) | 10-Aug-21 | Option Exercise | 21,381 | $5.78 | $123,688.00 | 199% 10.73K to 32.12K | |
| 09-Aug-21 7:21 AM View: | Marucci Anthony S President & CEO Director | AVANT Immunotherapeutics, I... (CLDX) | 05-Aug-21 | Option Exercise | 3,537 | $42.00 | $148,554.00 | 15% 23.69K to 27.23K | (5%) |
| 16-Dec-20 4:30 PM View: | Wright Richard M. Sr. VP & CCO | AVANT Immunotherapeutics, I... (CLDX) | 14-Dec-20 | Option Exercise | 20,832 | $6.21 | $129,365.00 | 10015% 0.21K to 21.04K | |
| 16-Dec-20 4:30 PM View: | Wright Richard M. Sr. VP & CCO | AVANT Immunotherapeutics, I... (CLDX) | 14-Dec-20 | Market Option Sale | 20,832 | $18.61 | $387,611.00 | (99%) 21.04K to 0.21K | 10% |
| 12-Jun-20 7:55 AM View: | Young Diane C. SVP, Chief Medical Officer | AVANT Immunotherapeutics, I... (CLDX) | 11-Jun-20 | Market Purchase | 2,115 | $4.73 | $10,004.00 | 100% 0 to 2.12K | 254% |
| 11-Jun-20 7:54 AM View: | Cavanaugh Sarah SVP of Corp Affairs & Admin. | AVANT Immunotherapeutics, I... (CLDX) | 10-Jun-20 | Market Purchase | 1,050 | $4.83 | $5,071.50 | 331% 0.32K to 1.37K | 246% |
| 10-Jun-20 7:54 AM View: | Keler Tibor Executive VP & CSO | AVANT Immunotherapeutics, I... (CLDX) | 09-Jun-20 | Market Purchase | 5,000 | $2.99 | $14,954.00 | 212% 2.36K to 7.36K | 459% |
| 10-Jun-20 7:55 AM View: | Heath-Chiozzi Margo SVP of Regulatory Affairs | AVANT Immunotherapeutics, I... (CLDX) | 09-Jun-20 | Market Purchase | 1,000 | $3.01 | $3,005.00 | 100% 0 to 1.0K | 456% |
